ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710895 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710895; 2) Community: the network communities that were significantly associated with the response to NSC 710895; 3) Molecule: the relationships between components within communities and NSC 710895; 4) MDR: the compounds that were significantly associated with the NSC 710895.

NSC Compound Enrichment Correlation
NSC 301457 Cycloalkannin 0.0385613993886001 0.55094865
NSC 303861 L-Cysteine analog 0.0385613993886001 0.44204267
NSC 30915 Null 0.0385613993886001 0.33265019
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.30753423
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0385613993886001 0.15205386
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.4328507
NSC 606497 Camptothecin Derivative 0.0385613993886001 -0.041830408
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.42347601
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0385613993886001 0.54608768
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0385613993886001 -0.21958517
Total:103  Current:70    [First] [Prev] [Next] [Last]